Under the market changes, pharmaceutical equipment companies have embarked on the road of differentiated innovation

【Pharmaceutical Network Market Analysis】The pharmaceutical equipment industry belongs to the direct upstream industry of the pharmaceutical industry, which is an important guarantee for
industrial upgrading and technological progress of the pharmaceutical industry.
At present, driven by many favorable policies, China's pharmaceutical industry is developing rapidly, and it has also driven the development of
the pharmaceutical equipment market.
It is reported that the domestic pharmaceutical equipment market has a complete range of products, basically covering the market of product categories, and domestic equipment by virtue of quality, price, maintenance and other advantages, is still accelerating the pace
of import substitution.
Pharmaceutical equipment enterprises have embarked on the road of differentiated innovation (Image source: Pharma.
com) It is worth mentioning that in the context of a good industrial development, constantly consolidating internal strength, improving innovation capabilities, and creating independent technology for pharmaceutical equipment have also become an important way
to achieve domestic pharmaceutical equipment from low-end to high-end.
In recent years, a large number of domestic pharmaceutical machinery enterprises have begun to explore and move forward in realizing independent innovation technology and deepening the field
.
Among them, many companies are also carrying out diversified and differentiated innovations in equipment and technology to further help pharmaceutical companies develop
with higher quality.
This is mainly due to the fact that, from the current development of the pharmaceutical equipment industry, as the cost of enterprises continues to rise year by year, the low-cost route has become unworkable, and simple innovation can not meet the complex environmental changes, so the differentiated competition route has gradually become a new path
for enterprise development.
Analysts believe that to seek a differentiated competition route, it is necessary to start from the actual situation of the enterprise itself, focus on the outstanding advantages of the enterprise, learn from each other's strong points, create competitive points, and widen the distance
with other enterprises and even products in the same industry.
It is reported that at present, many enterprises, including Chutian and Dongfulong, have begun to embark on the road of
differentiated innovation and upgrading.
For example, with the continuous development of automation and intelligent technology, Canaan Technology has been accelerating innovation and upgrading around automation, continuity, greening and
intelligence in recent years.
In the second half of 2021, with a total investment of 1 billion yuan, 3 standardized production workshops have been completed, and the rest are planned to be completed
in 2023.
It is worth noting that in order to open up the upstream and downstream expansion growth space, Canaan Technology also said that the future business focus will shift from production to service, and products will extend
from pharmaceutical stand-alone machines to complete lines and overall solutions.
At the same time, it will continue to be deeply involved in the entire life cycle of drugs, from front-end research and development to the final drug production, and can provide a complete set of solutions
.
At the moment of rapid development of the biomedical industry, Chutian Technology has introduced a number of experts in the front-end field of bioengineering in the past two years to carry out product research and development, promotion and sales
.
It is reported that Chutian plans to transform from equipment-based overall solutions to technology-based overall solution providers, of which bioengineering will be the focus of
the company's future development.
In addition, Dongfulong is firmly focusing on the development strategy of "systematization, internationalization and digitalization", developing innovative products with forward-looking and independent intellectual property rights in the fields of pharmaceutical equipment such as sterile injections and bioengineering, and is committed to providing global pharmaceutical customers with competitive and brand influence of overall system solutions
.
It can be seen from the above that R & D and design capabilities are the key points
of differentiated competition of pharmaceutical equipment enterprises.
At present, the needs of pharmaceutical companies are diversified, and in the case of rising costs year by year, compared with the research and development of a single pharmaceutical equipment, the overall solution provider can better meet the needs of enterprises, and this has become a major direction
for the upgrading of many domestic pharmaceutical equipment enterprises 。 Industry insiders believe that in the current situation of the intensification of changes in the pharmaceutical industry, pharmaceutical companies are increasing their demand for pharmaceutical equipment, and their requirements are also increasing, in this context, pharmaceutical equipment companies should always pay attention to the real needs of pharmaceutical companies while taking the differentiated route, create products that are more in line with the production requirements of enterprises, and improve service quality, in order to create higher value for pharmaceutical companies, enhance their market competitiveness, and promote the industry to achieve higher quality development
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice
to anyone.